Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$74.99
pos +0.00
+0.00%
Today's Range: 74.67 - 75.73 | LLY Avg Daily Volume: 4,418,800
Last Update: 05/27/16 - 4:03 PM EDT
Volume: 0
YTD Performance: -11.00%
Open: $0.00
Previous Close: $75.52
52 Week Range: $67.88 - $92.85
Oustanding Shares: 1,103,837,002
Market Cap: 83,361,770,391
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 0 0 0 0
Hold 4 4 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
Mean Rec. 1.86 1.86 1.77 1.50
Latest Dividend: 0.51
Latest Dividend Yield: 2.72%
Dividend Ex-Date: 05/11/16
Price Earnings Ratio: 34.56
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
34.56 34.70 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.89% 0.12% 38.51%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.70 -0.10 -0.04
Net Income 0.70 -0.40 -0.16
EPS 1.60 -0.40 -0.15
Earnings for LLY:
EBITDA 4.48B
Revenue 19.96B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.85 $0.92 $3.56 $3.92
Number of Analysts 7 5 10 9
High Estimate $0.90 $0.96 $3.60 $4.24
Low Estimate $0.80 $0.83 $3.54 $2.93
Prior Year $0.90 $0.89 $3.43 $3.56
Growth Rate (Year over Year) -5.24% 3.82% 3.94% 9.90%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

updateLLY Investor Mtg.

May 24, 2016 | 7:25 AM EDT

LLY - Eli Lilly and Co Investment Community R&D Update Meeting (Session 1) - 10AM New York City, NY

By

Bret Jensen

 | May 23, 2016 | 11:00 AM EDT

FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.

updateBofA/Merrill Healthcare Conf.

May 11, 2016 | 7:13 AM EDT

Bank of America Merrill Lynch Health Care Conference (Day 2 of 3) - 05/10/16 - 05/12/16 Las Vegas, NV

updateLLY Investor Mtg.

May 2, 2016 | 7:18 AM EDT

LLY - Eli Lilly and Co Annual Shareholders Meeting - 11AM

By

Bret Jensen

 | Apr 26, 2016 | 11:00 AM EDT

Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.

By

Jim Cramer

 | Apr 4, 2016 | 12:45 PM EDT

TheStreet's Jim Cramer isn't too fond of the pharmaceutical sector and he doesn't see that changing anytime soon.

By

Skip Raschke

 | Mar 23, 2016 | 9:15 AM EDT

Consider the LLY out-of-the-money, bearishly biased vertical put spread expiring in May.

By

Jim Cramer

 | Mar 21, 2016 | 12:51 PM EDT

TheStreet's Jim Cramer is concerned about what Eli Lilly has in its pipeline of new prospects.

By

Ed Ponsi

 | Mar 18, 2016 | 2:00 PM EDT

Let's review.

By

Skip Raschke

 | Mar 17, 2016 | 11:13 AM EDT

Closing this trade now as gains are sweet and should be locked in.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.